05/05/2022 Alzamend Neuro initiates its Phase IIa clinical trial with AL001 for mild to moderate AD Science watch
04/05/2022 FDA issues marketing approval for new in vitro diagnostic test for Alzheimer’s disease pathology Science watch
03/05/2022 BioXcel Therapeutics announces first participant dosed in its TRANQUILITY II Phase III Trial for agitation in AD Science watch
27/04/2022 TouchNEUROLOGY discusses diagnosis and precision management in early Alzheimer's disease with Dr Sharon Cohen Science watch
25/04/2022 TouchNEUROLOGY discusses potential role of inflammation in Alzheimer’s disease with Professor Jeffrey Cummings Science watch
22/04/2022 Biogen announces withdrawal of marketing authorisation application for aducanumab for the treatment of Alzheimer’s disease Science watch
22/04/2022 New clinical study shows that the performance of blood tests for Alzheimer's disease proteins varies between ethnic groups Science watch
20/04/2022 An accumulation of cardiovascular risk factors over time is linked to increased dementia risk, study finds Science watch
19/04/2022 Synaptogenix completes enrolment in its NIH sponsored Phase IIb trial for AD Science watch
05/04/2022 Sage Therapeutics reports preliminary results from its LUMINARY Phase 2 clinical trial for AD Science watch
